With comprehensive analysis of network pharmacology, transcriptomics, and artificial intelligence, eight ARDS-related targets were selected: SMAD4, HIF-1, AMPK, HRAS, SOD1, AKT2, RAC1, and P53. This evidence concerns the gene AKT2 and acute respiratory distress syndrome.